Assorted news links from the last week: Study Offers Insights on Health Problems among AYA Cancer Survivors
Medical trial aims to identify those at risk of heart damage following cancer treatment Australian researchers taking a very broad look at the effect of cancer treatment on heart health.
US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG, a big win for the Creating Hope Act (which needs to be permanently reauthorized by the end of September)
Risk-Stratified Therapy Reduces Late Morbidity, Mortality in Pediatric Acute Lymphoblastic Leukemia
Children With Cancer Not Experiencing as Severe COVID-19 as Initially Feared
Preserving Childhood Cancer Care Amid a Pandemic, U.S. News & World Report
